Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Behav Brain Res. 2016 Nov 3;319:96–103. doi: 10.1016/j.bbr.2016.10.050

Figure 3.

Figure 3

Treatment with the MOR agonist morphine (10 mg/kg, i.p.) or the KOR antagonist nor-BNI (10 mg/kg, i.p.) does not affect behavior in the NIH test 24 h post administration. There were no significant effects on A) approach latency in the NIH test or B) amount of food consumed in the novel arena. N = 10–22 per group.